Literature DB >> 17005676

Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.

Liang Deng1, Peihong Dai, Wanhong Ding, Richard D Granstein, Stewart Shuman.   

Abstract

Langerhans cells (LCs) are antigen-presenting cells in the skin that play sentinel roles in host immune defense by secreting proinflammatory molecules and activating T cells. Here we studied the interaction of vaccinia virus with XS52 cells, a murine epidermis-derived dendritic cell line that serves as a surrogate model for LCs. We found that vaccinia virus productively infects XS52 cells, yet this infection displays an atypical response to anti-poxvirus agents. Whereas adenosine N1-oxide blocked virus production and viral protein synthesis during a synchronous infection, cytosine arabinoside had no effect at concentrations sufficient to prevent virus replication in BSC40 monkey kidney cells. Vaccinia virus infection of XS52 cells not only failed to elicit the production of various cytokines, including tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-6, IL-10, IL-12 p40, alpha interferon (IFN-alpha), and IFN-gamma, it actively inhibited the production of proinflammatory cytokines TNF-alpha and IL-6 by XS52 cells in response to exogenous lipopolysaccharide (LPS) or poly(I:C). Infection with a vaccinia virus mutant lacking the E3L gene resulted in TNF-alpha secretion in the absence of applied stimuli. Infection of XS52 cells or BSC40 cells with the DeltaE3L virus, but not wild-type vaccinia virus, triggered proteolytic decay of IkappaBalpha. These results suggest a novel role for the E3L protein as an antagonist of the NF-kappaB signaling pathway. DeltaE3L-infected XS52 cells secreted higher levels of TNF-alpha and IL-6 in response to LPS and poly(I:C) than did cells infected with the wild-type virus. XS52 cells were productively infected by a vaccinia virus mutant lacking the K1L gene. DeltaK1L-infected cells secreted higher levels of TNF-alpha and IL-6 in response to LPS than wild-type virus-infected cells. Vaccinia virus infection of primary LCs harvested from mouse epidermis was nonpermissive, although a viral reporter protein was expressed in the infected LCs. Vaccinia virus infection of primary LCs strongly inhibited their capacity for antigen-specific activation of T cells. Our results highlight suppression of the skin immune response as a feature of orthopoxvirus infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005676      PMCID: PMC1617288          DOI: 10.1128/JVI.00354-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

Authors:  A Bowie; E Kiss-Toth; J A Symons; G L Smith; S K Dower; L A O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state.

Authors:  Dita Mayerova; Evan A Parke; Laura S Bursch; Oludare A Odumade; Kristin A Hogquist
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

3.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  Modified vaccinia virus Ankara induces moderate activation of human dendritic cells.

Authors:  Robert Drillien; Danièle Spehner; Daniel Hanau
Journal:  J Gen Virol       Date:  2004-08       Impact factor: 3.891

5.  Epidermal cells in activation of suppressor lymphocytes: further characterization.

Authors:  R D Granstein; M Askari; D Whitaker; G F Murphy
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

6.  The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.

Authors:  Joanna L Shisler; Xiao-Lu Jin
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset.

Authors:  J C Simon; P D Cruz; P R Bergstresser; R E Tigelaar
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

8.  Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.

Authors:  Gary DiPerna; Julianne Stack; Andrew G Bowie; Annemarie Boyd; Girish Kotwal; Zhouning Zhang; Sheila Arvikar; Eicke Latz; Katherine A Fitzgerald; William L Marshall
Journal:  J Biol Chem       Date:  2004-06-23       Impact factor: 5.157

9.  Epidermal Langerhans cells are derived from cells originating in bone marrow.

Authors:  S I Katz; K Tamaki; D H Sachs
Journal:  Nature       Date:  1979-11-15       Impact factor: 49.962

10.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  30 in total

1.  Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.

Authors:  Peihong Dai; Hua Cao; Taha Merghoub; Francesca Avogadri; Weiyi Wang; Tanvi Parikh; Chee-Mun Fang; Paula M Pitha; Katherine A Fitzgerald; Masmudur M Rahman; Grant McFadden; Xiaoyu Hu; Alan N Houghton; Stewart Shuman; Liang Deng
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection.

Authors:  Benedito Eduardo-Correia; Carles Martínez-Romero; Adolfo García-Sastre; Susana Guerra
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  DNA-triggered innate immune responses are propagated by gap junction communication.

Authors:  Suraj J Patel; Kevin R King; Monica Casali; Martin L Yarmush
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

4.  Cowpox virus induces interleukin-10 both in vitro and in vivo.

Authors:  April H Spesock; Brice E Barefoot; Caroline A Ray; Daniel J Kenan; Michael D Gunn; Elizabeth A Ramsburg; David J Pickup
Journal:  Virology       Date:  2011-06-11       Impact factor: 3.616

5.  A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosis.

Authors:  G Kung; P Dai; L Deng; R N Kitsis
Journal:  Cell Death Differ       Date:  2014-01-17       Impact factor: 15.828

Review 6.  Innate Antiviral Immunity in the Skin.

Authors:  Chelsea Handfield; Jeffery Kwock; Amanda S MacLeod
Journal:  Trends Immunol       Date:  2018-03-08       Impact factor: 16.687

7.  Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity.

Authors:  Chad Myskiw; Janilyn Arsenio; Craig Hammett; Rebekah van Bruggen; Yvon Deschambault; Nicole Beausoleil; Shawn Babiuk; Jingxin Cao
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

Review 8.  Function and regulation of retinoic acid-inducible gene-I.

Authors:  Tomoh Matsumiya; Diana M Stafforini
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

9.  Vaccinia virus A35R inhibits MHC class II antigen presentation.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Rachel L Roper
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

10.  Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.

Authors:  Liang Deng; Peihong Dai; Anthony Ciro; Donald F Smee; Hakim Djaballah; Stewart Shuman
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.